CID 135497803

Mirodenafil

Structural Information

Molecular Formula
C26H37N5O5S
SMILES
CCCC1=CN(C2=C1N=C(NC2=O)C3=C(C=CC(=C3)S(=O)(=O)N4CCN(CC4)CCO)OCCC)CC
InChI
InChI=1S/C26H37N5O5S/c1-4-7-19-18-30(6-3)24-23(19)27-25(28-26(24)33)21-17-20(8-9-22(21)36-16-5-2)37(34,35)31-12-10-29(11-13-31)14-15-32/h8-9,17-18,32H,4-7,10-16H2,1-3H3,(H,27,28,33)
InChIKey
MIJFNYMSCFYZNY-UHFFFAOYSA-N
Compound name
5-ethyl-2-[5-[4-(2-hydroxyethyl)piperazin-1-yl]sulfonyl-2-propoxyphenyl]-7-propyl-3H-pyrrolo[3,2-d]pyrimidin-4-one
Related CIDs

2D Structure

compound 2d structure
4
Annotation Hits

54
References

1345
Patents

531.2515 Da
Monoisotopic Mass

2.2
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 532.25878 231.3
[M+Na]+ 554.24072 238.1
[M-H]- 530.24422 233.0
[M+NH4]+ 549.28532 232.2
[M+K]+ 570.21466 230.1
[M+H-H2O]+ 514.24876 221.0
[M+HCOO]- 576.24970 235.7
[M+CH3COO]- 590.26535 241.7
[M+Na-2H]- 552.22617 227.6
[M]+ 531.25095 236.5
[M]- 531.25205 236.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe